ConductScience.org, home

Paper6366135

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

Fisher B and 9 others. J Clin Oncol, 1983. Cited by 255 papers, by iCite.

Cite this record

ConductScience Library. Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. Papers, record 6366135. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6366135

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.
PubMed
Journal
J Clin Oncol
PubMed
Year
1983
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
255
iCite
Relative citation ratio, by iCite
7.84
iCite
Revised in PubMed
2017-02-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fisher BB
2Redmond CC
3Brown AA
4Wickerham DLD L
5Wolmark NN
6Allegra JJ
7Escher GG
8Lippman MM
9Savlov EE
10Wittliff JJ

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Receptors, ProgesteroneMajor topic
TamoxifenMajor topic
Age Factors
Clinical Trials as Topic
Female
Fluorouracil
Humans
Lymph Nodes
Melphalan
Middle Aged
Prognosis
Statistics as Topic

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
N01-CB-23876NCI NIH HHSUnited StatesN01CB023876PubMed and NIHNIH RePORTER
R01-CA-12027NCI NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in18445835Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.https://conductscience.org/library/papers/18445835

Source PubMed

Download CSV of comments and corrections

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.

PMIDTitleJournalYearIn PapersSource
39924532An assessment of breast cancer HER2, ER, and PR expressions based on mammography using deep learning with convolutional neural networks.Sci Rep2025https://conductscience.org/library/papers/39924532PubMed
37192893ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy.Int J Nanomedicine2023https://conductscience.org/library/papers/37192893PubMed
37065867Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance.Cancer Drug Resist2023https://conductscience.org/library/papers/37065867PubMed
34625570A careful reassessment of anthracycline use in curable breast cancer.NPJ Breast Cancer2021https://conductscience.org/library/papers/34625570PubMed
33723286Pancancer survival analysis of cancer hallmark genes.Sci Rep2021https://conductscience.org/library/papers/33723286PubMed
33112838Serine synthesis influences tamoxifen response in ER+ human breast carcinoma.Endocr Relat Cancer2021https://conductscience.org/library/papers/33112838PubMed
32266132Sphingosine Kinase 1 in Breast Cancer-A New Molecular Marker and a Therapy Target.Front Oncol2020https://conductscience.org/library/papers/32266132PubMed
31359505Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas.J Clin Lab Anal2019https://conductscience.org/library/papers/31359505PubMed
31073534Precision Medicine.Annu Rev Stat Appl2019https://conductscience.org/library/papers/31073534PubMed
29858579Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer.Lab Invest2018https://conductscience.org/library/papers/29858579PubMed
29752560Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review.Curr Treat Options Oncol2018https://conductscience.org/library/papers/29752560PubMed
28971320Expression of Genes for Methylxanthine Pathway-Associated Enzymes Accompanied by Sex Steroid Receptor Status Impacts Breast Carcinoma Progression.Horm Cancer2017https://conductscience.org/library/papers/28971320PubMed
27619909Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.World J Surg Oncol2016https://conductscience.org/library/papers/27619909PubMed
27141007Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker.Clin Cancer Res2016https://conductscience.org/library/papers/27141007PubMed
26858530Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives.Pharmgenomics Pers Med2016https://conductscience.org/library/papers/26858530PubMed
26657878Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: Evaluation in Multicenter Studies.Appl Immunohistochem Mol Morphol2017https://conductscience.org/library/papers/26657878PubMed
25217578Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.J Natl Cancer Inst2014https://conductscience.org/library/papers/25217578PubMed
24199171In situ Protein Detection for Companion Diagnostics.Front Oncol2013https://conductscience.org/library/papers/24199171PubMed
23645940Estimating Optimal Treatment Regimes from a Classification Perspective.Stat2012https://conductscience.org/library/papers/23645940PubMed
23568563Protein tyrosine phosphatase 4A2 expression predicts overall and disease-free survival of human breast cancer and is associated with estrogen and progestin receptor status.Horm Cancer2013https://conductscience.org/library/papers/23568563PubMed

See all 56 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6366135

GET https://conductscience.org/api/papers/v1/6366135/cited_by?page=2